AITHM James Cook University


Back to listings

On Twitter

Latest tweets

Download Our
Annual Report

Currently there are no drugs specifically aimed at managing Peripheral Artery Disease in patients who are unlikely to benefit from intervention approaches. While there is significant interest in new therapeutic approaches, the challenge for researchers remains the inability to translate the results of pre-clinical animal trials to human patients. Professor Golledge, AITHM Senior Research Scientists Dr Joe Moxon and Dr Smriti Krishna, and the QRCPVD team, have examined the problem and found that there needs to be more representative models to evaluate therapies that could potentially translate to clinical practice.